40 results
8-K
EX-10.2
c84d87
29 Jun 23
Departure of Directors or Certain Officers
4:25pm
8-K
EX-10.1
limxvii2 d4ge41mbfn8
29 Jun 23
Departure of Directors or Certain Officers
4:25pm
8-K
EX-10.1
j5k6vnptbw r631lw
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
424B3
x7kksfg78wm0 drv
20 Apr 23
Prospectus supplement
4:32pm
S-4/A
jx2gq77bv95ezx0
18 Apr 23
Registration of securities issued in business combination transactions (amended)
4:01pm
S-4
8wez2cz9t tx94a8o
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm